A first-of-its-kind therapy that can delay the onset of type 1 diabetes for up to three years has been approved for use by the NHS.
The UK Government must ‘speed up access’ of new treatments for type 1 diabetes, says Nick Smith MP, as he joined campaigners in Westminster.
The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.
Artificial intelligence (AI) health-care technologies offer a means of addressing the growing gap between health-care ...
A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every ...
New research has analysed the proportion of patients aged 80 and over without disease who go on to develop referable ...
AI has become one of the NHS's biggest opportunities, and for good reason. From helping detect signs of disease in clinical ...
The immunotherpay can give children and adults three extra years before they need to use insulin.
For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...
Exclusive: Hundreds of thousands of patients have been r GP lists in the past 12 months – with one practice fearing patients ...
People have been told they could be offered an 'alternative search process' ...
A new community hub to help improve patients' eye health is to open. Situated at the Beacon of Light in Stadium Park, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results